A blog about Cystic Fibrosis, promoting organ donation, family, love, art, drinking too much tea (and quite possibly gin).
Sunday, 4 November 2018
Vaccines and herd immunity.
Monday, 22 October 2018
Mental health.
In my hard partying twenties I once found myself sobbing, literally paralysed at the top of the stairs in a pub, irrationally feeling 100% sure if I delved down into the basement toilets I would be attacked (anxiety induced paranoia).I became pretty agoraphobic at college for a while, alongside a weird addiction to watching Dallas repeats on UK gold.Even now, I can understand the addictive lure of self harm to release stress (I resist now, but didn’t always).Today I rely on a daily dose of Citralopram to keep my anxiety on an even keel (for me, this works, and if it ain’t broke, don’t fix it!);I use alcohol to self medicate for stress on a pretty regular basis....(not recommending that one).
Saturday, 20 October 2018
67
Saturday, 13 October 2018
Lakes and growing up.
Monday, 8 October 2018
A gene treatment?
Isaac has a fairly rare (severe) mutation of CF, which means he will not respond to the small molecule drugs that you may have heard about in the news of late, which should work for a wonderful 90% of people with CF. So what hope have we?
“About 10 percent of all CF mutations don’t allow for any CFTR protein — working or not — to be produced at all. Compounds can’t correct or potentiate a protein that doesn’t exist, so an entirely new approach is needed — one that might fix the CFTR gene itself. Vertex may be “the CF company,” but gene editing is not its expertise. So, it teamed with two companies: CRISPR Therapeutics and Moderna Therapeutics. Scientists discovered in 2014 a way to harness CRISPR/Cas9 — a mechanism used by some bacteria to prevent infection by viruses — to cut unwanted DNA from organisms, raising the possibility of doing so in people. The field has exploded since, with researchers worldwide testing CRISPR’s limits against genetic and other diseases in a kind of “scientific frenzy,” according to The New York Times. Vertex sees CRISPR as a possible pair of “molecular scissors,” acting to remove a dysfunctional CTFR gene before it is replaced with a working one – effectively curing the disease.
But CRISPR trials in CF patients aren’t likely anytime soon. “[W]e’re up for the challenge. We are working on it,” Altshuler said. “But anyone who’s serious about it realizes that there’s a multi-component aspect.”As Altshuler explained, “The DNA piece, or the correcting-the-gene piece, is the easy part.” The hard parts include editing to only affect targeted genes, while aiming at those in both mature lung cells and lung stem cells — which give rise to new cells — because cells in the lung turn over frequently. CRISPR is still in its infancy, and some scientists and bioethicists have already raised concerns about a limited understanding — and the possibility the tool might be more unpredictable than thought. A study in mice, published in the journal Nature Biotechnology in July, reported damage to genes beyond those targeted.A separate three-year research partnership was started in 2016 with Moderna Therapeutics, which specializes in a gene therapy approach targeting messenger RNA. Messenger RNA (mRNA) is involved in the transcription of genetic information, the first step in producing a protein.
“We hope it’s sooner, but we’ll work for 10 or 20 years to develop genetic therapies — or any other type of therapy — to treat those people living with CF who cannot take benefit from our small molecule or oral therapies,” Altshuler said. So, while its triple combinations appear to be zooming ahead, Vertex is with gene therapies about where it was in the early 1990s, screening for the small molecules that eventually became Kalydeco, Orkambi, and Symdeko.“I want to express … our deep commitment to completing our CF journey. We’ve made a lot of progress. We’re very proud of that,” Kewalramani said. “But we’re not going to rest until we get to all patients … our commitment is really unrelenting.”
It’s encouraging that they say they are committed, it really is. But also knowing the frustrations that come from NHS England and Vertex having yet to agree a deal which will allow people with CF access to one of their existing drugs (Orkambi) and the fact the ‘gene therapy’ was the buzz phrase when Isaac was born and yet still bears no fruit; it’s also a huge (head banging) frustration. These are as close to a cure that we can hope for right now.
We were told when he was born that the earliest we could hope for access to a treatment that would work on the underlying cause of his disease (rather than just the symptoms) was about five years. We’re 13 years and counting now, trying to keep his lungs as healthy as we can so that the treatments, when they do come, may still work for him.
So, I’m working on my next fundraising plan; we are bloody in this for the long term! Have a great day x
Thursday, 27 September 2018
This ain’t no lifestyle blog, dude!
And now the avocado on sourdough toast I had for supper......
Saturday, 22 September 2018
Happiness, flu jabs and another loss.
"Life isn't about being happy, life is a roller coaster of crazy emotions. One second you're fine, and the next second you feel lonely and despair and like nothing is ever going to be okay again. It's not about emotions, it's not about how you feel second to second. It's about what you're making with your life, and whether you can find a deep pride in who you are and what you've given. Because that is so much more impactful, so much deeper than whether you're happy or content or joyful. It's okay to feel pain." -
- Claire Wineland, an insanely uplifting and beautiful person, who died this month, following CF post transplant complications. This disease is so fucking cruel. Everyone should watch this. x
Wednesday, 19 September 2018
Roid fears.
Wednesday, 12 September 2018
Rhyme or reason
Sunday, 26 August 2018
Holiday and home.
Thursday, 9 August 2018
Vacances et espoir!
Wednesday, 8 August 2018
Clinic review tomorrow
Friday, 3 August 2018
Some news
Wednesday, 1 August 2018
Finding the car
Monday, 30 July 2018
Hospital and hoping for holidays...
Saturday, 28 July 2018
Sick sick....
Tuesday, 24 July 2018
Cystic Fibrosis FAQs
What is a portacath? Isaac had a portacath surgically implanted in his chest wall earlier this year, the aim being easy venous access for regular IV treatment (IV being intravenous, as in, drugs delivered directly into his blood stream).
Regular cannula/long line/PICC line access over the years has wrecked his veins, and it became harder and harder to find a viable vein each time (veins repeatedly used would just collapse resulting in multiple needles, and often, delayed treatment when he needed it most). We had an agonising wait in HDU (high dependency unit) once, and delayed antibiotics give bugs a chance to fight back. Not good.
The port meant surgery, always advisable to avoid, but the hope is that this will last him 5-10 years before replacement. Cancer patients often have a port for for chemotherapy.
He still requires a needle to access it for use, but the key difference is trying to guide a line up a long, thin, windy and collapsible vein, usually blind (they can use ultrasound, but this is unusual) which often fails and needs repeated attempts, compared to a needle plopped right into a kind of rubber bung with a hole in the centre, and ta dah... you have accessed the (pre-accessed) vein.
What does having a port mean to Isaac? On the whole, it’s great. When his port is not accessed you can see only a smallish bump under his skin in his chest (with one scar nearby and a second by his neck, from the surgery). When it is accessed for treatment, he has a needle in for the whole course (usually 2-3 weeks at a time) and cannot get this wet, so no swimming or showers. The rest of the time, it’s life as normal, aside from avoiding full contact sports like rugby, which might damage the port.
In between treatments, the port is accessed every month for a flush to keep it clear. So it does still involve regular needles, but compared to cannulas, long lines and PICC lines, overall, it is a helluva lot less stabs!
What would a Transplant mean to Isaac? CF is a multi factor disease, it affects mainly his lungs, pancreas, liver, sinuses, and digestive system. A lung transplant would only cure the disease in his lungs. But this is also where the biggest risk to life is (90% of people with CF die from lung disease).
After transplant, people with CF no longer have CF lungs. However, infections in their sinuses may re-infect their lungs, meaning they need to carry on with some traditional CF lung treatments (but not all, and maybe very few).
Digestive health is unaffected by lung transplant, for example, Isaac will always need to take Creon in order to digest fats and proteins (pancreatic enzyme replacement meds, of which he takes about 50 capsules a day) and will continue to be at risk of CF related osteoporosis, diabetes, some cancers and liver disease.
Why not transplant now? You will hear me shout loudly on this blog about organ donation and the fact that we have chronic shortage of donors.
1 in 3 people on the waiting list for lungs dies waiting
I have often been asked why Isaac cannot be put forward for transplant now? The good news is; he is too well. The main test of wellness is a lung function test. His FEV (forced expiratory volume) is measured regularly and forms part of the picture on which his team plan his treatment. I don’t like to post much about his FEV, as I feel it becomes a focus on a number which is only part of a much bigger picture. Plus it fluctuates widely, at his worst (while in intensive care) he blew a 17%. Needless to say, his baseline is never as high as I would like it to be, but also, it’s not near the point where transplantation would be considered (regularly less than 30%).
More importantly, transplantation is not a cure; the chances of surviving the surgery for a year is only 80% and surviving 5 years 60%. This is a fast changing statistic, as development in anti-rejection therapies improve. Transplant is truly amazing, and life changing for many, but it’s also like swapping one disease for another, and further, a whole new set of not so fun side effects.
More FAQ’s to follow. Any questions, because medical jargon slips into my vocabulary pretty quickly, please do ask x
Wednesday, 11 July 2018
A squash and a squeeze
Thursday, 5 July 2018
NHS England deny Orkambi access
Sunday, 1 July 2018
Heat wave and wild woods
Tuesday, 26 June 2018
Accessed and ready to go
Thursday, 21 June 2018
Yellow and IVs
- Cambridge is home to the first CF innovation hub. This will soon be on site at Addenbrookes, when the building is complete, and so we hope, gives us an increased chance of access to cutting edge clinical trials.
- The hub is focusing on infection and inflammation, the two biggest problems for lung health in CF. As well as drug discovery, they are looking at using smart tech in CF care, and regenerative therapies (its long been thought that once the lungs are damaged, there is little you can do to bring back that lung function, but stem cell regeneration may change that) and precision drugs.
- Our own Consultant presented a new iPhone app, that we have been involved in trials for, which gives kids a really cool game which responds to their breathing during physio. It can show not only how many breaths they have done, but how deeply, how long, and gives them an incentive to complete the physio (physio can take Isaac up to an hour every morning and every night, mostly due to chronic procrastination). The app even allows kids to play online against other kids with CF (who they could never meet, due to cross infection) which adds a social interaction they may benefit from. The app looks great, and would be especially good for younger kids in creating good habits, and in turn, help prevent much head banging for parents.
- The NHS is in a staffing crisis; in some areas up to one third of positions are not filled. With the fast growing CF population (CF used to be a disease of childhood only, but now, just over half of those with CF are now adults) this is a massive concern.
- Dr Charlie Howarth presented the new Papworth hospital building, now on site at Addenbrookes in Cambridge. The old Papworth hospital has a Cf population which has grown from 130 to 330 in 15 years. The new building offers many ensuite clinic rooms, theatres, nuclear medicine, 42 critical care beds, 25 room dedicated CF unit, all with ensuite, fridge and exercise machine, lifts which are segregated by what bugs you are infected with, high tech UV cleaning (kills all the bacteria in a room in 15 minutes), and 15 air changes per hour - all of which are designed to limit cross infection risks. Amazing!